Tag: Diabetes: Type II
Insulin Degludec/Liraglutide Noninferior to Insulin Glargine
Fixed ratio of degludec/liraglutide superior to continued titration of glargine in uncontrolled T2DM
Dispositional Mindfulness Tied to Improved Glucose Regulation
In adjusted analyses, no correlation for mindfulness with prevalence of type 2 diabetes
T2DM-Related Genetic Variants Predict All-Cause Mortality
Higher genetic risk linked to increased mortality risk, especially among obese non-Hispanic whites
Ferritin, Transferrin Positively Linked to Type 2 Diabetes
Higher levels tied to higher risk of T2D in men and women; TSAT linked to risk in women
NAFLD Linked to Unfavorable Metabolic Profile in T2DM
More severe hyperinsulinemia, dyslipidemia, and adipose tissue/hepatic insulin resistance with NAFLD
Durable Response With Insulin Pump Therapy in T2DM
Greater reduction in glycated hemoglobin with pump therapy versus multiple daily injections
App Can Up Adherence to Exercise in Diabetes
Personalized feedback via reinforcement learning improves glycemic control in type 2 diabetes
Neutral Long-Term Effect for Intensive Glycemic Control
Follow-up of patients from ACCORD trial shows neutral effect on primary composite outcome
Protein Preload Boosts Vildagliptin’s Effects in Diabetes
Small whey preload augments plasma intact GLP-1 levels, slows gastric emptying
No Benefit From Aliskiren-Tied Drops in Albuminuria
Overall albuminuria drop may be too small for cardiovascular, renal risk protection
